Patent details

Basic Information

Publication number:

EP1495053

PCT Application Number:

PCT/US/2002/032613

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP027804426

PCT Publication Number:

WO/2003/030833

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANGIOPOIETIN-2 AND ANGIOPOIETIN-1 SPECIFIC BINDING AGENTS

French Title of Invention:

AGENTS DE LIAISON SPECIFIQUES DES 'ANGIOPOIETINES-2 ET 1

German Title of Invention:

ANGIOPOIETIN-2-UND -1 -SPEZIFISCHE BINDUNGSMITTEL

SPC Number:

Dates

Filing date:

11/10/2002

Grant date:

13/06/2012

EP Publication Date:

13/06/2012

PCT Publication Date:

17/04/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/01/2005

EP B1 Publication Date:

13/06/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/10/2015

Expiration date:

11/10/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/10/2002

 

 

Name:

Amgen Inc.

Address:

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

20/06/2012

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

OLINER Johnathan, Daniel

Address:

United States (US)

Priority

1

Priority Number:

328604 P

Priority Date:

11/10/2001

Priority Country:

United States (US)

2

Priority Number:

269805

Priority Date:

10/10/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 16/22;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages